期刊文献+

氯地松乳膏治疗皮炎湿疹类皮肤病的临床疗效评价 被引量:4

Evaluation of Clinical Efficacy of Choramphenicol Dexamethasone Ointment for Dermatitis and Eczema
原文传递
导出
摘要 目的:评价氯地松乳膏治疗皮炎湿疹类皮肤病的疗效。方法:研究181例于我院门诊及住院部明确诊断为皮炎湿疹类皮肤病的患者,随机分为治疗组与对照组,给予患者相同外形、颜色、包装的氯地松乳膏(含地塞米松0.025%、氯霉素1%)及对照药物尿素乳膏,使用3周后比较2组疗效。结果:治疗组与对照组的有效率分别为78.57%、4.82%(P<0.001)。与对照组比较,治疗组患者症状改善明显。治疗组有3例出现给药部位皮肤发红及瘙痒感,1例出现给药部位毛发增粗,未发现其他全身或局部不良反应。结论:氯地松乳膏治疗皮炎湿疹类皮肤病安全、有效。 OBJECTIVE: To evaluate therapeutic efficacy of Choramphenicol dexamethasone ointment (0.025% dexametha- sone, 1% choramphenicol) in the treatment of dermatitis and eczema. METHODS: 181 out-patient and inpatient patients of our hospital diagnosed as dermatitis and eczema were divided into treatment group and control group randomly. All patients were given same package of Choramphenicol dexamethasone ointment or urea cream with same appearance and color and control. Therapeutic efficacies of dermatitis and eczema were observed and compared after 3 weeks of treatment. RESULTS: The effective rates were 78.57% in treatment group and 4.82% in control group (P〈0.001). Compared with control group, the symptoms were improved significantly in treatment group. In treatment group, 3 patients suffered from redness and itching of delivery site, and hair enlarge- ment of delivery site was found in 1 patient; no systemic or local ADR was found. CONCLUSION: Choramphenicol dexametha- sone ointment is safe and effective for dermatitis and eczema.
出处 《中国药房》 CAS CSCD 2013年第6期532-533,共2页 China Pharmacy
关键词 皮炎 湿疹 氯地松乳膏 疗效 安全性 Dermatitis Eczema Choramphenicol dexamethasone ointment Therapeutic efficacy Safety
  • 相关文献

参考文献3

二级参考文献16

  • 1弓娟琴,林麟,郝飞,陈艳,曾凡钦,李伯有,毕志刚,张美华,易东,赵辨.湿疹和特应性皮炎皮损处细菌定植情况及药物联合治疗的分析[J].中华皮肤科杂志,2004,37(9):515-518. 被引量:95
  • 2毕志刚,田美华,林麟,仇宁,郝飞,钟白玉,尹若菲,曾凡钦,赵辨.湿疹与特应性皮炎皮损处细菌学研究[J].中华皮肤科杂志,2004,37(10):595-597. 被引量:102
  • 3Abeck D, Mempel M. Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications. Br J Dermatol, 1998, 139Suppl 53:13-16.
  • 4Goh CL, Wong JS, Giam YC. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Center,Singapore. Int J Dermatol, 1997, 36: 653-657.
  • 5Breuer K, Haussler S, Kapp A, et al. Staphylococcus aureus: colonizaing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol, 2002, 147: 55-61.
  • 6Breuer K, Kapp A, Werfel T. Bacterial infections and atopic dermatitis. Allergy, 2001, 56: 1034-1041.
  • 7Leung DY. Atopic dermatitis and the immune system: the role of superantigens and bacteria. J Am Acad Dermatol, 2001, 45:S13-S16.
  • 8Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol, 1974, 90:525-530.
  • 9Feingold DS. Bacterial adherence, colonization, and pathogenicity.Arch Dermatol, 1986, 122:161-163.
  • 10Lever R, Hadley K, Downey D, et al. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol, 1988, 119: 189-198.

共引文献271

同被引文献22

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部